Inhibitor of cataract formation
US6914057B1 · kind B1 · utility
58Cited by
4References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 1999 |
| Grant date | Jul 5, 2005 |
| Priority date | — |
| Expiry date | Sep 28, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of reducing the risk of cataract development in a mammal are provided and include administering to the mammal an effective amount of a tetracycline derivative. A preferred tetracycline derivative administered according to the methods of the present invention is 6α-deoxy 5-hydroxy-4-dedimethylaminotetracycline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.